Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy

Metabolism. 2023 May:142:155531. doi: 10.1016/j.metabol.2023.155531. Epub 2023 Mar 3.

Authors

Marlene Chakhtoura¹, Christos S Mantzoros²

Affiliations

¹ Department of Internal Medicine, Division of Endocrinology, American University of Beirut Medical Center, Beirut, Lebanon.
² Beth Israel Deaconess Medical Center and Boston VA Healthcare system, Harvard Medical School, Boston, MA. Electronic address: cmantzor@bidmc.harvard.edu.

PMID: 36870600
DOI: 10.1016/j.metabol.2023.155531

No abstract available

Keywords: Obesity; Tirzepatide; Weight loss; Weight reducing medications.

Publication types

Editorial

MeSH terms

Anti-Obesity Agents* / therapeutic use
Humans
Obesity* / drug therapy

Substances

Anti-Obesity Agents